JP2017538735A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017538735A5 JP2017538735A5 JP2017532823A JP2017532823A JP2017538735A5 JP 2017538735 A5 JP2017538735 A5 JP 2017538735A5 JP 2017532823 A JP2017532823 A JP 2017532823A JP 2017532823 A JP2017532823 A JP 2017532823A JP 2017538735 A5 JP2017538735 A5 JP 2017538735A5
- Authority
- JP
- Japan
- Prior art keywords
- weight
- drug delivery
- delivery device
- copolymer
- adhesive composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000013271 transdermal drug delivery Methods 0.000 claims 15
- 239000000853 adhesive Substances 0.000 claims 14
- 230000001070 adhesive effect Effects 0.000 claims 14
- 229920001577 copolymer Polymers 0.000 claims 14
- PJMPHNIQZUBGLI-UHFFFAOYSA-N fentanyl Chemical compound C=1C=CC=CC=1N(C(=O)CC)C(CC1)CCN1CCC1=CC=CC=C1 PJMPHNIQZUBGLI-UHFFFAOYSA-N 0.000 claims 10
- 229960002428 fentanyl Drugs 0.000 claims 10
- 125000005250 alkyl acrylate group Chemical group 0.000 claims 8
- 230000004907 flux Effects 0.000 claims 7
- 239000000178 monomer Substances 0.000 claims 6
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 claims 4
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 claims 4
- 230000001186 cumulative effect Effects 0.000 claims 4
- 239000003961 penetration enhancing agent Substances 0.000 claims 4
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims 3
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 3
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 claims 2
- UQDUPQYQJKYHQI-UHFFFAOYSA-N methyl laurate Chemical compound CCCCCCCCCCCC(=O)OC UQDUPQYQJKYHQI-UHFFFAOYSA-N 0.000 claims 2
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 claims 2
- GOXQRTZXKQZDDN-UHFFFAOYSA-N 2-Ethylhexyl acrylate Chemical compound CCCCC(CC)COC(=O)C=C GOXQRTZXKQZDDN-UHFFFAOYSA-N 0.000 claims 1
- BHIZVZJETFVJMJ-UHFFFAOYSA-N 2-hydroxypropyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(C)O BHIZVZJETFVJMJ-UHFFFAOYSA-N 0.000 claims 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 claims 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 claims 1
- DXPPIEDUBFUSEZ-UHFFFAOYSA-N 6-methylheptyl prop-2-enoate Chemical compound CC(C)CCCCCOC(=O)C=C DXPPIEDUBFUSEZ-UHFFFAOYSA-N 0.000 claims 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 claims 1
- 239000011248 coating agent Substances 0.000 claims 1
- 238000000576 coating method Methods 0.000 claims 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 claims 1
- QQQMUBLXDAFBRH-UHFFFAOYSA-N dodecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)O QQQMUBLXDAFBRH-UHFFFAOYSA-N 0.000 claims 1
- 238000012377 drug delivery Methods 0.000 claims 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 claims 1
- 229940093471 ethyl oleate Drugs 0.000 claims 1
- 229960004063 propylene glycol Drugs 0.000 claims 1
- 229940026235 propylene glycol monolaurate Drugs 0.000 claims 1
- UWHCKJMYHZGTIT-UHFFFAOYSA-N tetraethylene glycol Chemical compound OCCOCCOCCOCCO UWHCKJMYHZGTIT-UHFFFAOYSA-N 0.000 claims 1
- 229940100640 transdermal system Drugs 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462094659P | 2014-12-19 | 2014-12-19 | |
| US62/094,659 | 2014-12-19 | ||
| PCT/US2015/066453 WO2016100708A1 (en) | 2014-12-19 | 2015-12-17 | Transdermal drug delivery device including fentanyl |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017538735A JP2017538735A (ja) | 2017-12-28 |
| JP2017538735A5 true JP2017538735A5 (enExample) | 2019-01-31 |
| JP6940407B2 JP6940407B2 (ja) | 2021-09-29 |
Family
ID=56127620
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017532823A Active JP6940407B2 (ja) | 2014-12-19 | 2015-12-17 | フェンタニルを含む経皮薬物送達デバイス |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20180263920A1 (enExample) |
| EP (1) | EP3233081B1 (enExample) |
| JP (1) | JP6940407B2 (enExample) |
| CN (1) | CN107106552A (enExample) |
| WO (1) | WO2016100708A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020084380A1 (en) | 2018-10-23 | 2020-04-30 | 3M Innovative Properties Company | Tamper evident transdermal patch |
| US11877848B2 (en) | 2021-11-08 | 2024-01-23 | Satio, Inc. | Dermal patch for collecting a physiological sample |
| US12178979B2 (en) | 2021-10-13 | 2024-12-31 | Satio, Inc. | Dermal patch for delivering a pharmaceutical |
| US12214346B2 (en) | 2021-10-13 | 2025-02-04 | Satio, Inc. | Dermal patch with a diagnostic test strip |
| US12053284B2 (en) | 2021-11-08 | 2024-08-06 | Satio, Inc. | Dermal patch for collecting a physiological sample |
| US12023156B2 (en) | 2021-10-13 | 2024-07-02 | Satio, Inc. | Dermal patch for collecting a physiological sample |
| US11964121B2 (en) | 2021-10-13 | 2024-04-23 | Satio, Inc. | Mono dose dermal patch for pharmaceutical delivery |
| US12029562B2 (en) | 2021-04-14 | 2024-07-09 | Satio, Inc. | Dermal patch system |
| US12048543B2 (en) | 2021-11-08 | 2024-07-30 | Satio, Inc. | Dermal patch for collecting a physiological sample with removable vial |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT610737A (enExample) | 1955-11-18 | 1900-01-01 | ||
| US3097008A (en) * | 1961-08-14 | 1963-07-09 | Arthur J Gravelle | Latch guard |
| US4588580B2 (en) * | 1984-07-23 | 1999-02-16 | Alaz Corp | Transdermal administration of fentanyl and device therefor |
| US4693776A (en) | 1985-05-16 | 1987-09-15 | Minnesota Mining And Manufacturing Company | Macromer reinforced pressure sensitive skin adhesive |
| US4732808A (en) | 1985-11-14 | 1988-03-22 | Minnesota Mining And Manufacturing Company | Macromer reinforced pressure sensitive skin adhesive sheet material |
| DE69517816T2 (de) | 1994-09-14 | 2000-12-28 | Minnesota Mining & Mfg | Matrix für transdermale wirkstofffreisetzung |
| TW411277B (en) * | 1996-05-13 | 2000-11-11 | Hisamitsu Pharmaceutical Co | Percutaneous tape preparation containing fentanyl |
| US20020119187A1 (en) * | 2000-09-29 | 2002-08-29 | Cantor Adam S. | Composition for the transdermal delivery of fentanyl |
| KR100904158B1 (ko) | 2001-03-16 | 2009-06-23 | 알자 코포레이션 | 펜타닐 투여용 경피성 패치 |
| JP3642316B2 (ja) * | 2001-06-15 | 2005-04-27 | 日本電気株式会社 | 化学増幅レジスト用単量体、化学増幅レジスト用重合体、化学増幅レジスト組成物、パターン形成方法 |
| DE10141650C1 (de) * | 2001-08-24 | 2002-11-28 | Lohmann Therapie Syst Lts | Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen |
| DE50310279D1 (de) | 2002-03-06 | 2008-09-18 | Hexal Ag | Transdermalsystem mit fentanyl |
| AU2003230034A1 (en) * | 2002-05-15 | 2003-12-02 | Thalas Group Incorporated | Transdermal delivery device for the administration of fentanyl |
| AR033748A1 (es) * | 2002-05-15 | 2004-01-07 | Thalas Group Inc | Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo |
| WO2003101433A1 (de) | 2002-05-28 | 2003-12-11 | LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH | Pflaster, enthaltend fentanylum |
| EP2319505A1 (en) * | 2003-04-30 | 2011-05-11 | Purdue Pharma L.P. | Transdermal dosage form comprising an active agent component and an adverse agent component in a ratio from 1:10 up to 10:1 |
| TW200745492A (en) * | 2006-02-22 | 2007-12-16 | Takiron Co | Surface light-emitting device |
| DE102006054733A1 (de) * | 2006-11-21 | 2008-05-29 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches Systems mit hoher Wirkstoffausnutzungsrate und Dosiergenauigkeit |
| RU2499583C2 (ru) * | 2007-10-15 | 2013-11-27 | Алза Корпорейшн | Заместительное трансдермальное введение фентанила один раз в день |
| WO2009051217A1 (ja) * | 2007-10-17 | 2009-04-23 | Hisamitsu Pharmaceutical Co., Inc. | フェンタニル含有経皮吸収製剤 |
| CN101780057B (zh) * | 2009-01-21 | 2012-09-05 | 考司美德制药株式会社 | 经皮吸收贴剂 |
| WO2011010556A1 (ja) * | 2009-07-23 | 2011-01-27 | ニプロパッチ株式会社 | 経皮吸収型製剤 |
| WO2012012417A1 (en) * | 2010-07-21 | 2012-01-26 | 3M Innovative Properties Company | Transdermal adhesive compositions, devices, and methods |
| KR20120107153A (ko) * | 2011-03-15 | 2012-10-02 | 아이큐어 주식회사 | 펜타닐 경피 패치제 |
| EP2711002A4 (en) * | 2011-05-20 | 2014-10-29 | Sk Chemicals Co Ltd | PLASTER WITH RIVASTIGMIN |
| US20140243765A1 (en) * | 2011-09-22 | 2014-08-28 | Samyang Biopharmaceuticals Corporation | Percutaneously absorbable preparation containing fentanyl and homologue thereof |
| EP2599478A1 (de) * | 2011-11-30 | 2013-06-05 | Acino AG | Transdermales therapeutisches System zur Verabreichung von Fentanyl oder einem Analogstoff davon |
-
2015
- 2015-12-17 EP EP15871096.2A patent/EP3233081B1/en active Active
- 2015-12-17 WO PCT/US2015/066453 patent/WO2016100708A1/en not_active Ceased
- 2015-12-17 US US15/537,579 patent/US20180263920A1/en not_active Abandoned
- 2015-12-17 JP JP2017532823A patent/JP6940407B2/ja active Active
- 2015-12-17 CN CN201580069281.9A patent/CN107106552A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017538735A5 (enExample) | ||
| US20240041791A1 (en) | Transdermal adhesive composition comprising a poorly soluble therapeutic agent | |
| JP2016504368A5 (enExample) | ||
| JP2013079281A5 (enExample) | ||
| JP2010510260A5 (enExample) | ||
| CN100450482C (zh) | 含有普拉克索活性剂的透皮治疗系统 | |
| JP2014508810A5 (enExample) | ||
| JP2012504163A5 (enExample) | ||
| JP2019523268A (ja) | 塩薬物のｉｎ ｓｉｔｕでの塩から中性の薬物変換による、低溶解度または不安定非イオン化中性薬物の経皮配合物および送達方法 | |
| RU2017125361A (ru) | Трансдермальная композиция, содержащая донепезил в качестве активного ингредиента | |
| JP2014503523A5 (enExample) | ||
| JP2016522792A5 (enExample) | ||
| JP2015508813A (ja) | ドネペジルを含有する経皮吸収製剤及びその製造方法 | |
| PH12015502280A1 (en) | Transdermal delivery system comprising donepezil or its salt | |
| JP6556873B2 (ja) | 経皮吸収製剤 | |
| CN103096882A (zh) | 含有多奈哌齐的经皮吸收制剂 | |
| MX382132B (es) | Sistema terapeutico transdermico que contiene asenapina y polisiloxano o poliisobutileno | |
| JP2016540060A5 (enExample) | ||
| US8852628B1 (en) | Transdermal drug delivery system for diclofenac | |
| EP3958866A1 (en) | Continuous delivery of lenalidomide and other immunomodulatory agents | |
| JP2014520871A5 (enExample) | ||
| JP2018525419A5 (enExample) | ||
| JP2014105205A (ja) | 医用貼付剤 | |
| JP2016513665A5 (enExample) | ||
| US20130281542A1 (en) | Selegiline transdermal system |